ketanserin has been researched along with phencyclidine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Furukawa, H; Harrer, SM; Hiramatsu, M; Jacobson, AE; Kameyama, T; Maeda, Y; Nabeshima, T; Noda, A; Rice, KC; Tohyama, K | 1 |
| Altar, CA; Marien, MR | 1 |
| Furukawa, H; Ishikawa, K; Kameyama, T; Nabeshima, T; Yamaguchi, K | 2 |
| Bakshi, VP; Geyer, MA; Swerdlow, NR | 1 |
| Hashimoto, K; Hirano, M; Hondo, H; Matsumoto, T; Nakamura, K; Nakane, H; Tsukashima, A; Tsutsumi, T; Uchimura, H; Yonezawa, Y | 1 |
| Abe, S; Baba, A; Hori, T; Moroji, T; Shiraishi, H; Suzuki, T; Yamamoto, T | 1 |
| Berardi, F; Giudice, G; Govoni, S; Lucchi, L; Perrone, R; Tortorella, V | 1 |
| Geyer, MA; Krebs-Thomson, K; Lehmann-Masten, V; Naiem, S; Paulus, MP | 1 |
| Ellison, G; Keys, A; Noguchi, K | 1 |
| Copolov, DL; Dean, B; Hayes, W; Hill, C; Hussain, T; Kitsoulis, S; Opeskin, K; Scarr, E | 1 |
| France, CP; Javors, MA; Koek, W; Li, JX; Rice, KC; Unzeitig, A | 1 |
| Abbas, AI; Beck, SG; Crawford, LK; Deneris, ES; Farrell, MS; Gingrich, J; Huang, XP; Irwin, JJ; Keiser, MJ; Kroeze, WK; Piel, DA; Roth, BL; Sciaky, N; Setola, V; Shoichet, BK; Yadav, PN | 1 |
1 review(s) available for ketanserin and phencyclidine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
16 other study(ies) available for ketanserin and phencyclidine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Effects of metaphit on phencyclidine and serotonin2 receptors.
Topics: Animals; Behavior, Animal; Ketanserin; Male; Phencyclidine; Rats; Rats, Inbred F344; Receptors, Neurotransmitter; Receptors, Phencyclidine; Receptors, Serotonin; Time Factors | 1989 |
[3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Autoradiography; Brain; Cholinergic Fibers; Frontal Lobe; Haloperidol; Hippocampus; Image Processing, Computer-Assisted; Ketanserin; Male; Neural Pathways; Neurotransmitter Uptake Inhibitors; Phencyclidine; Piperidines; Rats; Rats, Inbred Strains | 1988 |
Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents.
Topics: Animals; Behavior, Animal; Ethylmaleimide; Ketanserin; Male; Phencyclidine; Piperidines; Rats; Rats, Inbred F344; Receptors, Serotonin; Ritanserin; Serotonin; Sulfhydryl Reagents | 1988 |
Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.
Topics: Animals; Brain; Drug Interactions; Drug Tolerance; Ketanserin; Male; Methoxydimethyltryptamines; Methysergide; Phencyclidine; Rats; Rats, Inbred F344; Receptors, Serotonin; Stereotyped Behavior | 1987 |
Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
Topics: Acoustic Stimulation; Animals; Benzazepines; Clozapine; Dizocilpine Maleate; Ketanserin; Male; Phencyclidine; Raclopride; Rats; Rats, Sprague-Dawley; Reflex, Startle; Ritanserin; Salicylamides | 1994 |
Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Ketanserin; Locomotion; Male; Phencyclidine; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1995 |
Effects of phencyclidine metabolites on serotonin uptake in rat brain.
Topics: Animals; Brain; Ketanserin; Male; Paroxetine; Phencyclidine; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
Novel potent sigma 1 ligands: N-[omega-(tetralin-1-yl)alkyl]piperidine derivatives.
Topics: Animals; Hippocampus; Ketanserin; Phencyclidine; Piperidines; Rats; Receptors, Phencyclidine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, sigma; Spiperone; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.
Topics: Amphetamines; Animals; Ketanserin; Male; Motor Activity; Phencyclidine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Stereotyped Behavior | 1998 |
Long-term changes in brain following continuous phencyclidine administration: an autoradiographic study using flunitrazepam, ketanserin, mazindol, quinuclidinyl benzilate, piperidyl-3,4-3H(N)-TCP, and AMPA receptor ligands.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoradiography; Brain; Female; Flunitrazepam; Ketanserin; Ligands; Mazindol; Phencyclidine; Protein Binding; Quinuclidinyl Benzilate; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
Topics: Adult; Aged; Aged, 80 and over; Binding, Competitive; Female; Humans; Ketanserin; Male; Middle Aged; Neurons; Neurotransmitter Agents; Nitric Oxide Synthase; Phencyclidine; Prefrontal Cortex; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine; Receptors, GABA-A; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists; Tritium | 1999 |
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Ketamine; Ketanserin; Male; Morphine; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
The presynaptic component of the serotonergic system is required for clozapine's efficacy.
Topics: Acoustic Stimulation; Action Potentials; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Checkpoint Kinase 2; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Ketanserin; Lysine; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Patch-Clamp Techniques; Phencyclidine; Presynaptic Terminals; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Radioligand Assay; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Reflex, Startle; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Tritium; Tryptophan Hydroxylase | 2011 |